Paul Fields

4.1k citations
32 papers · 2.1k · 1 hit paper · h-index 17

Impact in

Papers in

    • SARS-CoV-2 and COVID-19 Research 6
    • Cancer Immunotherapy and Biomarkers 3
    • Pancreatic and Hepatic Oncology Research 1

Paul Fields

30 papers receiving 2.1k citations

Paul Fields's Hit Papers

Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment 2013 · 785 citations
7850+4+8Years since publication250500750

Peers

Paul Fields
Comparison fields: 5 of 54
  • Cancer Research 290
  • Infectious Diseases 291
  • Molecular Biology 536
  • Oncology 142
  • Genetics 101
Replace Xuanlin Huang with:
Xuanlin Huang China
Changying Jiang United States
Xue–Yuan Dong United States
Hideki Terai Japan
Florian Nolte Germany
Timothy Chevassut United Kingdom
Shengtao Zhu China
Aileen Cleary Cohen United States
Hisahiro Tabuchi Japan
Paul Fields relative to Xuanlin Huang China Xuanlin Huang's profile →
Citations per field
00.5×2×3×3.9×
Xuanlin Huang · 1×
Citations per year

Countries citing papers authored by Paul Fields

Since Specialization
Citations

This map shows the geographic impact of Paul Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fields more than expected).

Fields of papers citing papers by Paul Fields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fields. The network helps show where Paul Fields may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Fields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Fields Line = papers co-authored together Paul Fields links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
Hit paper breakdown →
2013785
2 2021254
3 2019163
4 2019118
5 202393
6 202183
7 201577
8 201958
9 201958
10 202355
11 201351
12 201649
13 200843
14 202032
15 202032
16 201930
17 202518
18 202216
19 202113
20 202213

About Paul Fields

Paul Fields is a scholar working on Infectious Diseases, Oncology, Transplantation, Molecular Biology and Hematology, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Genomics and Chromatin Dynamics (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Pluripotent Stem Cells Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), T-cell and B-cell Immunology (1 paper) and Cardiomyopathy and Myosin Studies (1 paper). The work is most often cited by research in Cancer Research (290 citations), Infectious Diseases (291 citations), Molecular Biology (536 citations), Oncology (142 citations) and Genetics (101 citations). Paul Fields has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Laurie A. Boyer, Lauren E. Surface, Vincent L. Butty, Matthew L. Steinhauser, Robert K. Bradley, Simon Haas, Huiming Ding, Johanna C. Scheuermann, Mohammadsharif Tabebordbar and Richard Theodore Lee. Their work appears in journals such as Frontiers in Immunology, Cell stem cell, Clinical Cancer Research, Science Translational Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact